NASDAQ:ARAY Accuray Q1 2026 Earnings Report $1.77 -0.08 (-4.32%) Closing price 04:00 PM EasternExtended Trading$1.80 +0.03 (+1.69%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast Accuray EPS ResultsActual EPSN/AConsensus EPS -$0.05Beat/MissN/AOne Year Ago EPSN/AAccuray Revenue ResultsActual RevenueN/AExpected Revenue$91.34 millionBeat/MissN/AYoY Revenue GrowthN/AAccuray Announcement DetailsQuarterQ1 2026Date11/5/2025TimeBefore Market OpensConference Call DateWednesday, November 5, 2025Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile Accuray Earnings HeadlinesAccuray announces first patient treated in Melbourne with CyberKnife S7 SystemOctober 8 at 12:30 AM | msn.comAccuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® SystemOctober 8 at 7:35 AM | prnewswire.comBig Oil Firm Stakes $1 Billion in Startup That Could Kill Big OilOn September 22, the unthinkable happened... One of the world's biggest oil producers poured $1 billion into a startup that could KILL the oil industry. This obscure startup is the front-runner in a technology that could generate virtually limitless energy.October 10 at 2:00 AM | Stansberry Research (Ad)Accuray Insider Ups Holding During YearOctober 2, 2025 | finance.yahoo.comAccuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient CareSeptember 30, 2025 | prnewswire.comAccuray Incorporated (ARAY) Shareholder/Analyst Call TranscriptSeptember 30, 2025 | seekingalpha.comSee More Accuray Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Accuray? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Accuray and other key companies, straight to your email. Email Address About AccurayAccuray (NASDAQ:ARAY) (NASDAQ: ARAY) is a global medical device company that develops, manufactures and markets innovative radiation therapy solutions for the treatment of cancer. The company’s flagship products include the CyberKnife® System, a robotic radiosurgery platform offering sub-millimeter precision, and the TomoTherapy® System, which combines helical computed tomography (CT) imaging with intensity-modulated radiation therapy (IMRT). More recently, Accuray introduced the Radixact® System, an advanced iteration of its TomoTherapy technology designed to enhance treatment speed and clinical workflow. Accuray’s suite of products enables clinicians to deliver highly targeted radiation doses while minimizing exposure to surrounding healthy tissue. The CyberKnife platform is widely used for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT), supporting treatments across a range of tumor types and anatomical sites. The TomoTherapy and Radixact systems incorporate integrated imaging, adaptive planning and dose-shaping capabilities that support daily adjustments in treatment delivery, helping to improve patient outcomes and operational efficiency in oncology centers. Founded in 1990 and headquartered in Madison, Wisconsin, Accuray serves a broad network of hospitals, cancer centers and research institutions in North America, Europe, Asia-Pacific and other regions. The company maintains additional offices and service centers in locations such as Sunnyvale, California; Milan, Italy; and Singapore to support its global customer base. Since September 2017, Accuray has been led by President and Chief Executive Officer Peter C. Arduini, whose background in medical technology and healthcare operations has guided the company’s focus on product innovation and clinical collaboration.View Accuray ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings Upcoming Earnings Fastenal (10/13/2025)BlackRock (10/14/2025)Citigroup (10/14/2025)The Goldman Sachs Group (10/14/2025)Johnson & Johnson (10/14/2025)JPMorgan Chase & Co. (10/14/2025)Wells Fargo & Company (10/14/2025)ASML (10/15/2025)Abbott Laboratories (10/15/2025)Bank of America (10/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
